{"id":"NCT02919111","sponsor":"University of California, San Francisco","briefTitle":"Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy Patients","officialTitle":"Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy Patients","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2016-09-23","primaryCompletion":"2019-12-31","completion":"2019-12-31","firstPosted":"2016-09-29","resultsPosted":"2020-12-10","lastUpdate":"2020-12-10"},"enrollment":299,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"DIAGNOSTIC"},"conditions":["Prostate Cancer"],"interventions":[{"type":"DRUG","name":"Ga-68 labeled PSMA-11 PET","otherNames":["Ga-68 labeled DKFZ-PSMA-11","Ga-68 labeled Glu-NH-CO-NH- Lys(Ahx)-HBED-CC","Ga-68 labeled Glu-urea- Lys(Ahx)-HBED-CC","Ga-68 labeled HBED-CC PSMA"]}],"arms":[{"label":"Ga-68 labeled PSMA-11 PET","type":"EXPERIMENTAL"}],"summary":"The investigators are imaging patients with prostate cancer using a new PET imaging agent (Ga-68-PSMA-11) in order to evaluate it's ability to detection prostate cancer in patients with high risk disease prior to prostatectomy.","primaryOutcome":{"measure":"Sensitivity of PSMA PET for the Detection of Regional Nodal Metastases Compared to Pathology at Radical Prostatectomy","timeFrame":"Up to 1 year","effectByArm":[{"arm":"Ga-68 Labeled PSMA-11 PET","deltaMin":0.43,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":4},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["37482512","34529005"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":299},"commonTop":[]}}